Abstract
Background
Uremia-associated immunodeficiency, mainly characterized by T cell dysfunction, exists in patients on maintenance hemodialysis (MHD) and promotes systemic inflammation. However, T cell senescence, one of the causes of T cell dysfunction, has not been clearly revealed yet. In this cross-sectional research, we aimed to study the manifestation of T cell premature senescence in MHD patients and further investigate the associated clinical factors.
Methods
76 MHD patients including 33 patients with cardiovascular diseases (CVD) and 28 patients with arteriovenous fistula (AVF) event history were enrolled in this study. Complementarity determining region 3 (CDR3) of T cell receptor (TCR) was analyzed by immune repertoire sequencing (IR-Seq). CD28- T cell subsets and expression of senescence marker p16 and p21 genes were detected by multicolor flow cytometry and RT-qPCR, respectively.
Results
MHD patients had significantly decreased TCR diversity (P < 0.001), increased CDR3 clone proliferation (P = 0.001) and a left-skewed CDR3 length distribution. The proportion of CD4 + CD28- T cells increased in MHD patients (P = 0.014) and showed a negative correlation with TCR diversity (P = 0.001). p16 but not p21 expression in T cells was up-regulated in MHD patients (P = 0.039). Patients with CVD exhibited increased expression of p16 and p21 genes (P = 0.010 and 0.004, respectively), and patients with AVF events showed further TCR diversity and evenness reduction (P = 0.002 and 0.017, respectively) compared to patients without the comorbidities. Moreover, age, average convection volume, total cholesterol, high-density lipoprotein cholesterol and transferrin saturation were associated with TCR diversity or CD4 + CD28- T cell proportion (P < 0.05).
Conclusions
MHD patients undergo T cell premature senescence characterized by significant TCR diversity reduction and repertoire skew, as well as accumulation of the CD4 + CD28- subset and up-regulation of p16 gene. Patients with CVD or AVF events show higher level of immunosenescence. Furthermore, T cell senescence in MHD patients is associated with blood cholesterol and uremic toxin retention, suggesting potential intervention strategies in the future.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Betjes MG. Uremia-Associated Ageing of the Thymus and adaptive Immune responses. Toxins. 2020;12:224.
Cohen G. Immune Dysfunction in Uremia 2020. Toxins. 2020;12:439.
Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2018;33:iii28–34.
Rocchetti MT, Cosola C, Ranieri E, Gesualdo L. Protein-bound uremic toxins and immunity. Methods Mol Biol Clifton NJ. 2021;2325:215–27.
Wu H, Dong J, Yu H, Wang K, Dai W, Zhang X, et al. Single-cell RNA and ATAC sequencing reveal hemodialysis-related Immune Dysregulation of circulating Immune Cell subpopulations. Front Immunol. 2022;13:878226.
Losappio V, Franzin R, Infante B, Godeas G, Gesualdo L, Fersini A, et al. Molecular mechanisms of premature aging in Hemodialysis: the Complex interplay between Innate and Adaptive Immune Dysfunction. Int J Mol Sci. 2020;21:3422.
Sampani E, Stangou M, Daikidou D-V, Nikolaidou V, Asouchidou D, Dimitriadis C, et al. Influence of end stage renal disease on CD28 expression and T-cell immunity. Nephrol Carlton Vic. 2021;26:185–96.
Dedeoglu B, de Weerd AE, Huang L, Langerak AW, Dor FJ, Klepper M, et al. Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation. Clin Exp Immunol. 2017;188:299–310.
**ang F, Chen R, Cao X, Shen B, Chen X, Ding X, et al. Premature aging of circulating T cells predicts all-cause mortality in hemodialysis patients. BMC Nephrol. 2020;21:271.
**aoyan J, Rongyi C, Xuesen C, Jianzhou Z, Jun J, **aoqiang D, et al. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality. BMC Nephrol. 2019;20:301.
van Riemsdijk IC, Baan CC, Loonen EHM, Knoop CJ, Betonico GN, Niesters HGM, et al. T cells activate the tumor necrosis factor-α system during hemodialysis, resulting in tachyphylaxis. Kidney Int. 2001;59:883–92.
Meier P, Dayer E, Ronco P, Blanc E. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4 + T cell subset in patients with end-stage renal failure. Clin Nephrol. 2005;63:8–21.
**ang F, Cao X, Chen X, Zhang Z, Ding X, Zou J, et al. Decreased peripheral Naïve T cell number and its Role in Predicting Cardiovascular and infection events in Hemodialysis patients. Front Immunol. 2021;12:644627.
Ducloux D, Legendre M, Bamoulid J, Saas P, Courivaud C, Crepin T. End-stage renal disease-related Accelerated Immune Senescence: is rejuvenation of the Immune System a therapeutic goal? Front Med. 2021;8:720402.
Iio K, Kabata D, Iio R, Shibamoto S, Watanabe Y, Morita M, et al. Decreased thymic output predicts progression of chronic kidney disease. Immun Ageing A. 2023;20:8.
Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–90.
Naylor K, Li G, Vallejo AN, Lee W-W, Koetz K, Bryl E, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174:7446–52.
Shawi M, Autexier C. Telomerase, senescence and ageing. Mech Ageing Dev. 2008;129:3–10.
Ben-Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest. 2004;113:8–13.
Yousefzadeh MJ, Zhao J, Bukata C, Wade EA, McGowan SJ, Angelini LA, et al. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell. 2020;19:e13094.
Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128:1238–46.
Martínez-Zamudio RI, Dewald HK, Vasilopoulos T, Gittens‐Williams L, Fitzgerald‐Bocarsly P, Herbig U. Senescence‐associated β‐galactosidase reveals the abundance of senescent CD8 + T cells in aging humans. Aging Cell. 2021;20:e13344.
Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG et al. Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8:439–48.
Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80:572–86.
Wang L, Dai Y, Liu S, Lai L, Yan Q, Chen H, et al. Assessment of variation in B-cell receptor heavy chain repertoire in patients with end-stage renal disease by high-throughput sequencing. Ren Fail. 2019;41:1–13.
Huang L, Betjes MGH, Klepper M, Langerak AW, Baan CC, Litjens NHR. End-stage renal disease causes skewing in the TCR Vβ-Repertoire primarily within CD8 + T cell subsets. Front Immunol. 2017;8:1826.
Huang L, Langerak AW, Wolvers-Tettero ILM, Meijers RWJ, Baan CC, Litjens NHR, et al. End stage renal disease patients have a skewed T cell receptor Vβ repertoire. Immun Ageing. 2015;12:28.
Zhang X, Zeng J, Tong Y, Zhang L, Lu X, Zhu S, et al. CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity. FEBS Open Bio. 2020;10:2702–11.
Liu X, Cui Y, Zhang Y, Liu Z, Zhang Q, Wu W, et al. A comprehensive study of immunology repertoires in both preoperative stage and postoperative stage in patients with colorectal cancer. Mol Genet Genomic Med. 2019;7:e504.
Ahmed M, Lanzer KG, Yager EJ, Adams PS, Johnson LL, Blackman MA. Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J Immunol. 2009;182:784–92.
Libby P, Egan D, Skarlatos S. Roles of Infectious agents in atherosclerosis and Restenosis1. Circulation. 1997;96:4095–103.
Zal B, Kaski JC, Arno G, Akiyu JP, Xu Q, Cole D, et al. Heat-shock protein 60-Reactive CD4 + CD28null T cells in patients with Acute Coronary syndromes. Circulation. 2004;109:1230–5.
Zal B, Chitalia N, Ng YS, Trieu V, Javed S, Warrington R, et al. Killer cell immunoglobulin receptor profile on CD4 + CD28 – T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients. Immunology. 2015;145:105–13.
Brugaletta S, Biasucci LM, Pinnelli M, Biondi-Zoccai G, Giannuario GD, Trotta G, et al. Novel anti‐inflammatory effect of statins: reduction of CD4 + CD28null T lymphocyte frequency in patients with unstable angina. Heart. 2006;92:249–50.
Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2:85–95.
Kim HY, Yoo T-H, Hwang Y, Lee GH, Kim B, Jang J, et al. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Sci Rep. 2017;7:3057.
Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ. CD28 loss in senescent CD4 + T cells: reversal by interleukin-12 stimulation. Blood. 2003;101:3543–9.
Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-α1. J Immunol. 2001;167:3231–8.
Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130:1715–25.
Rosko A, Hofmeister C, Benson D, Efebera Y, Huang Y, Gillahan J, et al. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transpl. 2015;50:1379–81.
Kelesidis T, Jackson N, McComsey G, Wang X, Elashoff D, Dube M, et al. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS Lond Engl. 2016;30:2625–33.
Cao H, Meng X. HDL and Kidney Diseases. In: Zheng L, editor. HDL Metab Dis [Internet]. Singapore: Springer Nature; 2022 [cited 2023 Oct 29]. pp. 163–70. https://doi.org/10.1007/978-981-19-1592-5_13.
Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C, et al. Uremia alters HDL composition and function. J Am Soc Nephrol JASN. 2011;22:1631–41.
Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med. 2023;389:700–9.
Rostoker G, Griuncelli M, Loridon C, Magna T, Machado G, Drahi G, et al. Reassessment of Iron biomarkers for prediction of Dialysis Iron overload: an MRI study. PLoS ONE. 2015;10:e0132006.
Ducloux D, Legendre M, Bamoulid J, Rebibou J-M, Saas P, Courivaud C, et al. ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications. Immun Ageing. 2018;15:16.
Acknowledgements
We appreciate all the patients and healthy volunteers who willingly participated and were involved in this study.
Funding
This study was funded by the National Natural Science Foundation of China (81970610, 82000634), the Shanghai Science/Technology Commission/Animal Special Program (22140903900), the Program of Shanghai Academic/Technology Research Leader (22XD1431400), the Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant (20172015) and Shanghai Sailing Program (20YF1425000).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. LG designed the study. WW, AS, KX, HP, RL and LG were responsible for the subject recruitment and the informed consent. WW, AS, KX, JL, BZ, CQ, MW, LM and WH were responsible for clinical data collection and validation. WW, AS, KX, JL and BZ conducted the laboratory tests and statistical analysis. WW, AS and KX wrote the original draft. LG, RL and HP revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This study was approved by the Ethics Committee of Shanghai Jiao Tong University School of Medicine, Renji Hospital (LY2023-098-B). All the participants provided written informed consent.
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Communicated by L Li.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, W., Song, A., **e, K. et al. Characteristics of T cell premature senescence in maintenance hemodialysis patients. Inflamm. Res. (2024). https://doi.org/10.1007/s00011-024-01897-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00011-024-01897-2